The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI has launched an advisory board of oncology experts to provide guidance and strategic advice to the Chicago-based company on research, product development and clinical use of it's AI-enabled ...

Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance ...

BofA lowered the firm’s price target on Tempus AI (TEM) to $48 from $60 and keeps a Neutral rating on the shares. Sentiment for Life Sciences ...

Illumina (ILMN) and Tempus AI (TEM) announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel ...

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas ...

(RTTNews) - Illumina Inc. (ILMN) and Tempus AI, Inc. (TEM), Tuesday announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation.

NASDAQ:TEM opened at $42.12 on Thursday. The stock’s 50 day moving average price is $56.19 and its two-hundred day moving average price is $50.92. Tempus AI has a 12-month low of $22.89 and a 12 ...

Detailed price information for Coreweave Inc Cl A (CRWV-Q) from The Globe and Mail including charting and trades.

Financial giants have made a conspicuous bullish move on Tempus AI. Our analysis of options history for Tempus AI TEM revealed 15 unusual trades. Delving into the details, we found 53% of traders ...